Dr Gerald Liew, MBBS (Hons), MMed (Hons), PhD, FRANZCO, is conducting research which includes clinical trials for treatments for retinal conditions, methods to improve diagnosis and monitoring of macular diseases, and investigating the genetic basis of retinal diseases such as macular degeneration. He has been awarded a Master of Medicine and Doctorate from the University of Sydney and has published widely. He is a Clinical Senior Lecturer with the Westmead Clinical School.
In 2015 Dr Gerald Liew was awarded a Macular Disease Foundation Australia Research Grant for $100,000 over one year.
Dr Liew's research project is entitled 'Deciphering the metabolomics signature of age-related macular degeneration to discover pathogenic pathways'.
This project is a pilot study to analyse the systemic metabolites which are altered as a result of macular degeneration. Metabolomics is a very new area of medical research involving analysis of large amounts of data from many patients to generate hypotheses about the disease process, which can then be tested. This study will investigate whether certain metabolites that result from the age-related macular degeneration disease process may enable the development of a simple blood test which could be used as an early marker for disease progression.
The project will involve collaboration with the Bioanalytic Mass Spectroscopy Facility at the University of New South Wales.